05:39 PM EST, 11/11/2024 (MT Newswires) -- Sonoma Pharmaceuticals ( SNOA ) said late Monday the US Food and Drug Administration has granted a new 510(k) clearance for its Microcyn technology-based hydrogel for wound treatment.

The clearance allows the product to be used, under the supervision of a healthcare professional, for wounds associated with dermal irritation, sores, injuries and ulcers of dermal tissue, first and second degree burns, diabetic ulcers, and mechanically or surgically-debrided wounds, the company said.

The clearance applies to 50 milliliter bottles with a shelf life of 24 months, it said.

Price: 2.9600, Change: -0.14, Percent Change: -4.52